Table 3.

Results of univariate and mutivariate logistic regression analysis to show relationship between DPP4 drugs and arthralgia/arthritis

		Arthralgia/Arthritis
		Yes(n=60)	No(n=140)	OR[95%CI]	P	ORa[95%CI]	Pa
DPP4 usage	Yes			3.77 [1.98-7.17]]	0.001‡	2.7 1[1.34-5.40]	0.001‡
Type of DPP4	Saxagliptin	6	88	3.09 [0.98-9.71]	0.054	3.55 [1.09-11.59]	0.036‡
	Sitagliptin	21	9	4.05 [1.88-8.73]	0.001‡	4.03 [1.84-8.85]	0.001‡
	Vildagliptin	14	24	3.41 [1.46-7.98]	0.005‡	3.32 [1.39-7.91]	0.007‡
	Non-users	19	19	1(reference)		1(reference)
Duration of DPP4 (year)		1.95±1.41	0.98±0.83	2.43 [1.44-4.12]	0.001‡	2.51 [1.47-4.30]	0.001‡

OR: Odds ratio; CI: Confidence Interval a: Adjusted by Gender;

* Continuous variables (mean± std);

† Ordinal or Binary variable (n(%));

‡ Significant at p<0.05.